Effects of Mismatching for Minor Histocompatibility Antigens on Clinical Outcomes in HLA-Matched, Unrelated Hematopoietic Stem Cell Transplants

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 7, 2009, Pages 856-863

  Spellman, Stephen ^a   Warden, Melissa B ^b   Haagenson, Michael ^c   Pietz, Bradley C ^b   Goulmy, Els ^d   Warren, Edus H ^e   Wang, Tao ^f   Ellis, Thomas M ^b  

^a NATIONAL MARROW DONOR PROGRAM   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Fred Hutchinson Cancer Research Center   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Graft versus host disease antigens; Marrow and stem cell transplantation; Minor histocompatibility antigens; Unrelated donor transplantation

Indexed keywords

BUSULFAN; CALCINEURIN INHIBITOR; CD31 ANTIGEN; CYCLOPHOSPHAMIDE; HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA A3 ANTIGEN; HLA A8 ANTIGEN; HLA ANTIGEN; HLA B1 ANTIGEN; MELPHALAN; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC LEUKEMIA; DONOR; ENGRAFTMENT; FEMALE; GENOTYPE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; PROGNOSIS; RELAPSE; SCHOOL CHILD; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHILD; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MINOR HISTOCOMPATIBILITY ANTIGENS; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 67149139830     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.03.018     Document Type: Article

References (38)

1. Appelbaum F.R. The current status of hematopoietic cell transplantation. Annu Rev Med 54 (2003) 491-512
2. Champlin R.E., Schmitz N., Horowitz M.M., et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 95 (2000) 3702-3709
3. Mohty M., Bay J.-O., Faucher C., et al. Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen. Blood 102 (2003) 470-476
4. Atkinson K., Horowitz M.M., Gale R.P., et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 75 (1990) 2459-2464
5. Champlin R.E., Passweg J.R., Zhang M.-J., et al. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood 95 (2000) 3996-4003
6. Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110 (2007) 4576-4583
7. Malarkannan S., Regunathan J., and Timler A.M. Minor histocompatibility antigens: molecular targets for immunomodulation in tissue transplantation and tumor therapy. Clin Appl Immunol Rev 5 (2005) 95-109
8. Roopenian D., Choi E.Y., and Brown A. The immunogenomics of minor histocompatibility antigens. Immunol Rev 190 (2002) 86-94
9. Simpson E., Roopenian D., and Goulmy E. Much ado about minor histocompatibility antigens. Immunol Today 19 (1998) 108-112
10. Akatsuka Y., Nishida T., Kondo E., et al. Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens. J Exp Med 197 (2003) 1489-1500
11. Brickner A.G., Warren E.H., Caldwell J.A., et al. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 193 (2001) 195-206
12. de Bueger M., Bakker A., Van Rood J.J., et al. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells. Eur J Immunol 21 (1991) 2839-2844
13. Marijt W.A., Veenhof W.F., Goulmy E., et al. Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact. Blood 82 (1993) 3778-3785
14. Spierings E., Brickner A.G., Caldwell J.A., et al. The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood 102 (2003) 621-629
15. Vogt M.H., de Paus R.A., Voogt P.J., et al. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood 95 (2000) 1100-1105
16. Vogt M.H., Goulmy E., Kloosterboer F.M., et al. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood 96 (2000) 3126-3132
17. Dolstra H., Fredrix H., Maas F., et al. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J Exp Med 189 (1999) 301-308
18. Dolstra H., Fredrix H., Preijers F., et al. Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL. J Immunol 158 (1997) 560-565
19. Bleakley M., and Riddell S.R. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer 4 (2004) 371-380
20. Goulmy E., Schipper R., Pool J., et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 334 (1996) 281-285
21. Tseng L.H., Lin M.T., Hansen J.A., et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 94 (1999) 2911-2914
22. Marijt W.A., Heemskerk M.H., Kloosterboer F.M., et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 100 (2003) 2742-2747
23. Grumet F.C., Hiraki D.D., Brown B.W.M., et al. CD31 mismatching affects marrow transplantation outcome. Biol Blood Marrow Transplant 7 (2001) 503-512
24. Cavanagh G., Chapman C.E., Carter V., et al. Donor CD31 genotype impacts on transplant complications after human leukocyte antigen-matched sibling allogeneic bone marrow transplantation. Transplantation 79 (2005) 602-605
25. Pietz B.C., Warden M.B., DuChateau B.K., et al. Multiplex genotyping of human minor histocompatibility antigens. Hum Immunol 66 (2005) 1174-1182
26. Flomenberg N., Weisdorf D., Baxter-Lowe L.A., et al. Impact of HLA class I and class II high resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplant outcome. Blood 104 (2004) 1923-1930
27. Johnson S.C., Marshall D.J., and Harms G. Multiplexed genetic analysis using an expanded genetic alphabet. Clin Chem 50 (2004) 2019-2027
28. Prudent J. Using expanded genetic alphabets to simplify high-throughput genetic testing. Expert Rev Mol Diagn 6 (2006) 245-252
29. de Bueger M., Verreck F., Blokland E., et al. Isolation of an HLA-A2.1 extracted human minor histocompatibility peptide. Eur J Immunol 23 (1993) 614-618
30. den Haan J.M., Meadows L.M., Wang W., et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 279 (1998) 1054-1057
31. Pierce R.A., Field E.D., Mutis T., et al. The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol 167 (2001) 3223-3230
32. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18 (1974) 295-304
33. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 69
34. Perez-Garcia A., De la Camara R., Torres A., et al. Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantation. Haematologica 90 (2005) 1723-1724
35. Gallardo D., Arostegui J.I., Balas A., et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 114 (2001) 931-936
36. Marijt E.A., Veenhof W.F., Goulmy E., et al. Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation. Hum Immunol 37 (1993) 221-228
37. Shaw B., Gooley T., Malkki M., et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood 110 (2007) 4560-4566
38. Spierings E., Hendriks M., Absi L., et al. Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations. PLoS Genet 3 (2007) e103